drugset / Trial / NCT00052130
Vaccine Therapy for Patients With Stage III Melanoma
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase 3 study in patients with melanoma that has spread to the lymph nodes (stage III), and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CancerVax | Vaccine | — | — |